Ep. Winer et al., SILICONE CONTROVERSY - A SURVEY OF WOMEN WITH BREAST-CANCER AND SILICONE IMPLANTS, Journal of the National Cancer Institute, 85(17), 1993, pp. 1407-1411
Background: During the past 3 years, there has been a highly publicize
d debate concerning the potential medical complications of silicone br
east implants. There have been no studies that have addressed the effe
ct of this controversy on women with a history of breast cancer who ha
ve undergone breast reconstruction with silicone implants. Purpose: Th
is study was undertaken to understand the concerns of such women regar
ding their breast reconstructions and to assess what impact the silico
ne implant controversy had on them. Methods: One hundred seventy-four
randomly selected women who had undergone reconstructive surgery with
silicone implants subsequent to mastectomy for treatment of breast can
cer were interviewed by telephone from February through May 1992. (A m
oratorium on use of silicone breast implants, imposed by the Food and
Drug Administration, extended from January through April 1992.) These
women, a subset of 359 mastectomy/reconstruction patients of one unive
rsity-based plastic surgeon, had their first permanent prostheses plac
ed between 1985 and 1990. The interview included questions designed to
elicit information about women's experiences with reconstruction and
reactions to the controversy. Results: All study participants were awa
re of the controversy surrounding silicone implants. Seventy-six perce
nt stated that breast reconstruction helped them cope with cancer, and
only 16% had regrets about reconstruction. Many respondents had misco
nceptions about the nature of possible complications from silicone imp
lants. Fifty-five percent were worried about the implants, vet only 13
% considered having them removed as a result of the controversy. Only
27% indicated they would be completely likely to choose silicone impla
nts again. The majority of women were unwilling to accept substantial
risks of complications from implants, but there was variability in the
level of risk that respondents would tolerate. Conclusions: A majorit
y of women who have had breast reconstruction using silicone implants
after treatment of breast cancer believe that implants helped them cop
e with the cancer. However, a sizeable proportion of such women are wo
rried about possible medical complications that may develop as a conse
quence of silicone breast implants. Many would likely not choose these
implants today. Implications: The true risks associated with silicone
implants will ultimately be known. In the meantime, health care provi
ders need to address patients' concerns about these implants. Informat
ion and guidance regarding the potential benefits and risks of breast
implant devices should be provided to women with breast cancer who are
considering treatment options.